| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/19/2013 | EP2604621A1 Method and Carrier Complexes for Delivering Molecules to Cells |
| 06/19/2013 | EP2604610A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof |
| 06/19/2013 | EP2604606A1 Inhibitor of casein kinase 1 and casein kinase 1 |
| 06/19/2013 | EP2604603A1 Crystal forms of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide and methods for their preparation |
| 06/19/2013 | EP2604601A1 Hetero ring compound |
| 06/19/2013 | EP2604287A2 Method and Carrier Complexes for Delivering Molecules to Cells |
| 06/19/2013 | EP2604286A1 Method and Carrier Complexes for Delivering Molecules to Cells |
| 06/19/2013 | EP2604285A1 Method and Carrier Complexes for Delivering Molecules to Cells |
| 06/19/2013 | EP2604284A1 Receptor And Antigen Targeted Prodrug |
| 06/19/2013 | EP2604283A1 Receptor And Antigen Targeted Prodrug |
| 06/19/2013 | EP2604280A2 Compositions and methods for inhibiting PDGFRBETA and VEGF-A |
| 06/19/2013 | EP2604279A1 Compositions and methods for inhibiting PDGFRBETA and VEGF-A |
| 06/19/2013 | EP2604278A1 Anti-KIR antibodies, formulations, and uses thereof |
| 06/19/2013 | EP2604277A1 Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent |
| 06/19/2013 | EP2604276A1 Use of antibodies against nk1, nk2 and/or nk3 receptors in cancer treatment |
| 06/19/2013 | EP2604275A1 Use of Recombinant LAG-3 or the Derivatives Thereof for Eliciting Monocyte Immune Response |
| 06/19/2013 | EP2604274A1 Rhus verniciflua stokes extract having increased content of active flavonoid compound and method for preparing same |
| 06/19/2013 | EP2604271A1 A stem cell-derived microvesicle (MV) for use in inhibiting apoptosis induced by a cytostatic agent |
| 06/19/2013 | EP2604263A1 Medicinal agent for prevention and/or treatment of hepatocellular carcinoma |
| 06/19/2013 | EP2604261A2 SCCA-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient |
| 06/19/2013 | EP2603527A1 Humanized egfr antibodies |
| 06/19/2013 | EP2603520A2 Erythrocyte-binding therapeutics |
| 06/19/2013 | EP2603288A1 Pharmaceutical granulate comprising imatinib mesylate |
| 06/19/2013 | EP2603239A2 Neuropilin as a biomarker for bevacizumab combination therapies |
| 06/19/2013 | EP2603227A2 Improved hematopoietic stem and progenitor cell therapy |
| 06/19/2013 | EP2603224A1 Methods and compositions for preventing a condition |
| 06/19/2013 | EP2603223A1 Recombinant tumor vaccine and method of producing such vaccine |
| 06/19/2013 | EP2603222A1 Combinatory cancer treatment |
| 06/19/2013 | EP2603082A1 Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin |
| 06/19/2013 | EP2603078A1 Combination |
| 06/19/2013 | CN1950343B Basic amine compound and use thereof |
| 06/19/2013 | CN1798834B Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclon |
| 06/19/2013 | CN1668335B Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 06/19/2013 | CN103168039A Imidazopyridines syk inhibitors |
| 06/19/2013 | CN103168031A Tetrahydroquinoline derivatives used as AMPK activators |
| 06/19/2013 | CN103167882A Novel use of a yt cell line for the therapy of malignant diseases and viral infections and for producing interferon gamma |
| 06/19/2013 | CN103167876A Improved hematopoietic stem and progenitor cell therapy |
| 06/19/2013 | CN103167870A Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| 06/19/2013 | CN103167867A Solid dispersions containing an apoptosis-inducing agent |
| 06/19/2013 | CN103160557A Purpose of ribosomal protein S5 in catalyzing of protein molecules for generatation of dephosphorylation reaction |
| 06/19/2013 | CN103160537A Application method of long-chain non-coding ribonucleic acid (RNA) gene in preparation of interference inhibitor |
| 06/19/2013 | CN103160531A NGR-VEGI fusion protein as well as encoding gene and expression and purification method thereof |
| 06/19/2013 | CN103160513A MUC1 protein nucleic acid aptamer, complex, composition and purposes thereof |
| 06/19/2013 | CN103160512A Nucleic acid, drug carrier, pharmaceutical composition and preparation method of drug carrier and pharmaceutical composition |
| 06/19/2013 | CN103159828A 1-(4-hydroxy-3-methoxycarbonyl)-beta-carboline-3-formyl tryptophyl amino acid benzyl ester, and synthesis and application thereof |
| 06/19/2013 | CN103159822A Preparation method of triptolide and ramification composition thereof |
| 06/19/2013 | CN103159821A Lanostane triterpenoid and application thereof |
| 06/19/2013 | CN103159814A Gambogic acid ester derivative as well as preparation method and use thereof |
| 06/19/2013 | CN103159760A Azaindole derivatives as cftr modulators |
| 06/19/2013 | CN103159748A Preparation and application of 2-(1H-1, 2, 3-triazole-4-group) aniline compounds |
| 06/19/2013 | CN103159742A 5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound serving as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor |
| 06/19/2013 | CN103159741A Preparation and application of novel tyrosine kinase inhibitor |
| 06/19/2013 | CN103159740A Preparation and application of 1, 5-distributed-1, 2, 3-triazole trifluoromethyl type compound |
| 06/19/2013 | CN103159739A 1, 4-disubstituted-1, 2, 3-triazole compounds and preparation method thereof |
| 06/19/2013 | CN103159736A Substitutional pyrazol kinase inhibitor |
| 06/19/2013 | CN103159735A Substitutional imidazole kinase inhibitor |
| 06/19/2013 | CN103159729A Alpha-, gamma-mangostin derivative and application in anti-cancer drug preparation thereof |
| 06/19/2013 | CN103159691A Preparing method and application of isothiocyanate compound |
| 06/19/2013 | CN103159690A Crystallization form of symmetric macrocyclic amine compound |
| 06/19/2013 | CN103159680A Imidazole diketone compound and application thereof |
| 06/19/2013 | CN103159674A 2-benzene alkyl amid compound and preparation method, medical composition and use thereof |
| 06/19/2013 | CN103159667A 6-guanidyl-2H-isoindole compound as well as preparation method and application thereof |
| 06/19/2013 | CN103159652A Preparation and application of sulfonamide compound |
| 06/19/2013 | CN103159650A Preparation and application of aromatic heterocyclic sulfonamide compound |
| 06/19/2013 | CN103159649A Preparation of sulfonamides compounds and application of sulfonamides compounds |
| 06/19/2013 | CN103159646A Hydroxamic acid compound, and preparation method and application thereof |
| 06/19/2013 | CN103159621A Stilbene active component, preparation method and application thereof |
| 06/19/2013 | CN103157118A Composite nano-grade novel material based on cancer early-stage integrated detection, diagnoses, and treatment, and preparation method thereof |
| 06/19/2013 | CN103157117A Medicine for regulating and controlling TRAIL (Tnf (Tumor necrosis factor) Related Apoptosis Inducing Ligand) tolerance of tumour |
| 06/19/2013 | CN103157116A Novel cancer suppressor gene UNC5D and new applications of encoded protein thereof |
| 06/19/2013 | CN103157115A Application of human RHBDD1 gene and drugs related to gene |
| 06/19/2013 | CN103157114A Purposes and related medicines of human ZNF786 gene |
| 06/19/2013 | CN103157109A CD146 and antibody diagnosis thereof, and application in treating triple negative breast cancer |
| 06/19/2013 | CN103157108A An immunomodulator composition, and a pharmaceutical composition and applications thereof |
| 06/19/2013 | CN103157063A Chinese herbal medicine compound preparation for tumor inhibition and preparation method thereof |
| 06/19/2013 | CN103157062A Medicine composition curing gynaecological mass diseases such as fibroids and preparation method and application thereof |
| 06/19/2013 | CN103157057A Application of amomum fruit or alcohol extract thereof to preparation of medicine for resisting proliferation of breast cancer cell |
| 06/19/2013 | CN103157055A Traditional Chinese medicine preparation for treating hyperplasia of mammary glands |
| 06/19/2013 | CN103157041A Preparation method of medicine for treating multiple osteoenchondroma |
| 06/19/2013 | CN103157040A Pharmaceutical composition for treating multiple osteoenchondroma |
| 06/19/2013 | CN103157032A Postoperative medicine for chondroblastoma |
| 06/19/2013 | CN103157031A Preparation method of postoperative medicine for chondroblastoma |
| 06/19/2013 | CN103157014A Miao medicine for treating tumors |
| 06/19/2013 | CN103157012A Hmong drug for treating cyclomastopathy |
| 06/19/2013 | CN103156986A Traditional Chinese medicine preparation for treating neurofibroma |
| 06/19/2013 | CN103156966A Female natural pudenda protection health liquid |
| 06/19/2013 | CN103156952A Medicament for treating esophageal cancer |
| 06/19/2013 | CN103156951A Combined medicament for treating B cell lymphoma |
| 06/19/2013 | CN103156922A Application of radix fici hirtae in preparing anti-tumor medicine |
| 06/19/2013 | CN103156906A Thyroid carcinoma treatment soup preparation method |
| 06/19/2013 | CN103156891A Preparation method of akebia fruit active components and preparation method of preparation of akebia fruit active components and application in preparation of antineoplastic medicines of preparation of foreknowledge sub-active components |
| 06/19/2013 | CN103156884A Functions of seminal plasma |
| 06/19/2013 | CN103156878A Phellinus baumii polysaccharide and OPC (Oligomeric Proantho Cyanidins) slow-release micro-capsules |
| 06/19/2013 | CN103156877A Capecitabine immediate-release pellet and preparation method thereof |
| 06/19/2013 | CN103156872A Adriamycin compound and preparation method thereof |
| 06/19/2013 | CN103156871A Method of avoiding phenomenon of accelerating blood clearance by continuously and repeatedly injecting polyethylene glycol (PEG) lipidosome of epirubicin hydrochloride |
| 06/19/2013 | CN103156848A Application of SR48692 in preparation of anti-glioma medicaments or health care products |
| 06/19/2013 | CN103156838A Medicinal application of chromone compound |
| 06/19/2013 | CN103156020A Nasopharyngeal carcinoma prevention and treatment tea preparation method |
| 06/19/2013 | CN102872128B Application of Houttuynoid E in medicament for preventing lung cancer metastasis |